STME Stimcell Energetics Inc.
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1493712 · Fiscal year ends 05/31
Financial factors as of 2026-08-31 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-4.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-2,067.1%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets3,334.9%
Debt / equity—
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.39x
Accruals ratio-1,257.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2026*2026-05-31 | FY2025*2025-05-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| SG&A expense | $382,560 | $213,452 |
| Interest expense | $69,348 | $38,256 |
| Net income | -$895,375 | -$566,293 |
| EPS (basic) | -0.04 | -0.03 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $3,057 | $14,581 |
| Total assets | $81,454 | $21,222 |
| Total liabilities | $1.89M | $1.27M |
| Shareholders' equity | -$1.81M | -$1.25M |
| Cash flow statement | ||
| Operating cash flow | -$312,081 | -$141,600 |
| Financing cash flow | $300,582 | $112,858 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.